Detection of Galactomannan Antigenemia by Enzyme Immunoassay for the Diagnosis of Invasive Aspergillosis: Variables That Affect Performance

Invasive aspergillosis (IA) is a frequent complication of blood or marrow transplantation. Previous studies have reported that the Aspergillus galactomannan enzyme immunoassay (GM EIA) may be a useful diagnostic tool for IA, but its sensitivity is variable. We examined the performance of the GM EIA...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of infectious diseases 2004-08, Vol.190 (3), p.641-649
Hauptverfasser: Marr, Kieren A., Balajee, S. Arunmozhi, McLaughlin, Lisa, Tabouret, Marc, Bentsen, Christopher, Walsh, Thomas J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 649
container_issue 3
container_start_page 641
container_title The Journal of infectious diseases
container_volume 190
creator Marr, Kieren A.
Balajee, S. Arunmozhi
McLaughlin, Lisa
Tabouret, Marc
Bentsen, Christopher
Walsh, Thomas J.
description Invasive aspergillosis (IA) is a frequent complication of blood or marrow transplantation. Previous studies have reported that the Aspergillus galactomannan enzyme immunoassay (GM EIA) may be a useful diagnostic tool for IA, but its sensitivity is variable. We examined the performance of the GM EIA in 986 serum samples from 67 patients. Results demonstrated that decreasing the index cutoff for positivity to 0.5 increased its sensitivity, with minimal loss of specificity. The low cutoff increased the duration of test positivity before diagnosis by clinical means. Sensitivity was highest in patients who did not receive preventative mold-active antifungals (87.5%). A rabbit model demonstrated that the level of circulating antigen correlated with the tissue fungus burden. A quantifiable response to antifungal therapy in clinical samples and the rabbit model supports the development of this assay for early diagnosis and therapeutic monitoring. The 0.5 cutoff may allow for better performance as an early diagnostic test.
doi_str_mv 10.1086/422009
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_66688570</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>30077638</jstor_id><oup_id>10.1086/422009</oup_id><sourcerecordid>30077638</sourcerecordid><originalsourceid>FETCH-LOGICAL-c481t-92dc0e28b410891821c3ac361d1d0d0f5185f9fe90a8056ea8ef4f9d120d5be73</originalsourceid><addsrcrecordid>eNqFkdFu0zAUhiMEYt2ANwCZSXAXOLYTx-aubGOtNAkuCpq4sdzkuHNJ7GInE-UVeGlStdoQEuLKF_-n7_icP8ueUXhDQYq3BWMA6kE2oSWvciEof5hNABjLqVTqKDtOaQ0ABRfV4-yIlqzgquCT7Nc59lj3LngSLLk0ran70BnvjSdT37sVeuycIcstufA_tx2SedcNPpiUzJbYEEl_g-TcmZUPyaWdZO5vTXK3SKZpg3Hl2naXvCNfTHRm2WIiixvTk6m142DyCeNoGSfW-CR7ZE2b8OnhPck-f7hYnM3yq4-X87PpVV4Xkva5Yk0NyOSyGDdXVDJac1NzQRvaQAO2pLK0yqICI6EUaCTawqqGMmjKJVb8JHu9925i-D5g6nXnUo1tazyGIWkhhJRlBf8FqQSuOOyMp3-B6zBEPy6hGeOKMlrQe1sdQ0oRrd5E15m41RT0rkS9L3EEXxxsw7LD5h47tDYCrw6ASbVpbRyv59IfnCqVorv_v9xzYdj8e9jzPbNOfYh3FAeoKsHlmOf73KUef9zlJn7TouJVqWfXXzV7P1PXFV1oyX8DkTHGeg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>223912141</pqid></control><display><type>article</type><title>Detection of Galactomannan Antigenemia by Enzyme Immunoassay for the Diagnosis of Invasive Aspergillosis: Variables That Affect Performance</title><source>MEDLINE</source><source>Jstor Complete Legacy</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Marr, Kieren A. ; Balajee, S. Arunmozhi ; McLaughlin, Lisa ; Tabouret, Marc ; Bentsen, Christopher ; Walsh, Thomas J.</creator><creatorcontrib>Marr, Kieren A. ; Balajee, S. Arunmozhi ; McLaughlin, Lisa ; Tabouret, Marc ; Bentsen, Christopher ; Walsh, Thomas J.</creatorcontrib><description>Invasive aspergillosis (IA) is a frequent complication of blood or marrow transplantation. Previous studies have reported that the Aspergillus galactomannan enzyme immunoassay (GM EIA) may be a useful diagnostic tool for IA, but its sensitivity is variable. We examined the performance of the GM EIA in 986 serum samples from 67 patients. Results demonstrated that decreasing the index cutoff for positivity to 0.5 increased its sensitivity, with minimal loss of specificity. The low cutoff increased the duration of test positivity before diagnosis by clinical means. Sensitivity was highest in patients who did not receive preventative mold-active antifungals (87.5%). A rabbit model demonstrated that the level of circulating antigen correlated with the tissue fungus burden. A quantifiable response to antifungal therapy in clinical samples and the rabbit model supports the development of this assay for early diagnosis and therapeutic monitoring. The 0.5 cutoff may allow for better performance as an early diagnostic test.</description><identifier>ISSN: 0022-1899</identifier><identifier>EISSN: 1537-6613</identifier><identifier>DOI: 10.1086/422009</identifier><identifier>PMID: 15243943</identifier><identifier>CODEN: JIDIAQ</identifier><language>eng</language><publisher>Chicago, IL: The University Chicago Press</publisher><subject>Adolescent ; Adult ; Aged ; Animals ; Antifungals ; Antigens, Fungal - blood ; Aspergillosis ; Aspergillosis - diagnosis ; Aspergillosis - microbiology ; Aspergillus ; Aspergillus - isolation &amp; purification ; Biological and medical sciences ; Bone marrow ; Bone Marrow Transplantation - adverse effects ; Child ; Child, Preschool ; Disease Models, Animal ; Female ; Fundamental and applied biological sciences. Psychology ; Fungal infections ; Fungemia - diagnosis ; Fungemia - microbiology ; Fungi ; Health care administration ; Humans ; Immunoenzyme Techniques ; Infections ; Infectious diseases ; Lung Diseases, Fungal - diagnosis ; Lung Diseases, Fungal - microbiology ; Male ; Mannans - blood ; Medical sciences ; Microbiology ; Middle Aged ; Neutropenia ; Rabbits ; Sensitivity and Specificity ; Symptoms</subject><ispartof>The Journal of infectious diseases, 2004-08, Vol.190 (3), p.641-649</ispartof><rights>Copyright 2004 Infectious Diseases Society of America</rights><rights>2004 by the Infectious Diseases Society of America 2004</rights><rights>2004 INIST-CNRS</rights><rights>Copyright University of Chicago Press Aug 1, 2004</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c481t-92dc0e28b410891821c3ac361d1d0d0f5185f9fe90a8056ea8ef4f9d120d5be73</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/30077638$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/30077638$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,778,782,801,27911,27912,58004,58237</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15959910$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15243943$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Marr, Kieren A.</creatorcontrib><creatorcontrib>Balajee, S. Arunmozhi</creatorcontrib><creatorcontrib>McLaughlin, Lisa</creatorcontrib><creatorcontrib>Tabouret, Marc</creatorcontrib><creatorcontrib>Bentsen, Christopher</creatorcontrib><creatorcontrib>Walsh, Thomas J.</creatorcontrib><title>Detection of Galactomannan Antigenemia by Enzyme Immunoassay for the Diagnosis of Invasive Aspergillosis: Variables That Affect Performance</title><title>The Journal of infectious diseases</title><addtitle>J Infect Dis</addtitle><addtitle>J Infect Dis</addtitle><description>Invasive aspergillosis (IA) is a frequent complication of blood or marrow transplantation. Previous studies have reported that the Aspergillus galactomannan enzyme immunoassay (GM EIA) may be a useful diagnostic tool for IA, but its sensitivity is variable. We examined the performance of the GM EIA in 986 serum samples from 67 patients. Results demonstrated that decreasing the index cutoff for positivity to 0.5 increased its sensitivity, with minimal loss of specificity. The low cutoff increased the duration of test positivity before diagnosis by clinical means. Sensitivity was highest in patients who did not receive preventative mold-active antifungals (87.5%). A rabbit model demonstrated that the level of circulating antigen correlated with the tissue fungus burden. A quantifiable response to antifungal therapy in clinical samples and the rabbit model supports the development of this assay for early diagnosis and therapeutic monitoring. The 0.5 cutoff may allow for better performance as an early diagnostic test.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Animals</subject><subject>Antifungals</subject><subject>Antigens, Fungal - blood</subject><subject>Aspergillosis</subject><subject>Aspergillosis - diagnosis</subject><subject>Aspergillosis - microbiology</subject><subject>Aspergillus</subject><subject>Aspergillus - isolation &amp; purification</subject><subject>Biological and medical sciences</subject><subject>Bone marrow</subject><subject>Bone Marrow Transplantation - adverse effects</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Disease Models, Animal</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fungal infections</subject><subject>Fungemia - diagnosis</subject><subject>Fungemia - microbiology</subject><subject>Fungi</subject><subject>Health care administration</subject><subject>Humans</subject><subject>Immunoenzyme Techniques</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Lung Diseases, Fungal - diagnosis</subject><subject>Lung Diseases, Fungal - microbiology</subject><subject>Male</subject><subject>Mannans - blood</subject><subject>Medical sciences</subject><subject>Microbiology</subject><subject>Middle Aged</subject><subject>Neutropenia</subject><subject>Rabbits</subject><subject>Sensitivity and Specificity</subject><subject>Symptoms</subject><issn>0022-1899</issn><issn>1537-6613</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkdFu0zAUhiMEYt2ANwCZSXAXOLYTx-aubGOtNAkuCpq4sdzkuHNJ7GInE-UVeGlStdoQEuLKF_-n7_icP8ueUXhDQYq3BWMA6kE2oSWvciEof5hNABjLqVTqKDtOaQ0ABRfV4-yIlqzgquCT7Nc59lj3LngSLLk0ran70BnvjSdT37sVeuycIcstufA_tx2SedcNPpiUzJbYEEl_g-TcmZUPyaWdZO5vTXK3SKZpg3Hl2naXvCNfTHRm2WIiixvTk6m142DyCeNoGSfW-CR7ZE2b8OnhPck-f7hYnM3yq4-X87PpVV4Xkva5Yk0NyOSyGDdXVDJac1NzQRvaQAO2pLK0yqICI6EUaCTawqqGMmjKJVb8JHu9925i-D5g6nXnUo1tazyGIWkhhJRlBf8FqQSuOOyMp3-B6zBEPy6hGeOKMlrQe1sdQ0oRrd5E15m41RT0rkS9L3EEXxxsw7LD5h47tDYCrw6ASbVpbRyv59IfnCqVorv_v9xzYdj8e9jzPbNOfYh3FAeoKsHlmOf73KUef9zlJn7TouJVqWfXXzV7P1PXFV1oyX8DkTHGeg</recordid><startdate>20040801</startdate><enddate>20040801</enddate><creator>Marr, Kieren A.</creator><creator>Balajee, S. Arunmozhi</creator><creator>McLaughlin, Lisa</creator><creator>Tabouret, Marc</creator><creator>Bentsen, Christopher</creator><creator>Walsh, Thomas J.</creator><general>The University Chicago Press</general><general>University of Chicago Press</general><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>M7N</scope><scope>7X8</scope></search><sort><creationdate>20040801</creationdate><title>Detection of Galactomannan Antigenemia by Enzyme Immunoassay for the Diagnosis of Invasive Aspergillosis: Variables That Affect Performance</title><author>Marr, Kieren A. ; Balajee, S. Arunmozhi ; McLaughlin, Lisa ; Tabouret, Marc ; Bentsen, Christopher ; Walsh, Thomas J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c481t-92dc0e28b410891821c3ac361d1d0d0f5185f9fe90a8056ea8ef4f9d120d5be73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Animals</topic><topic>Antifungals</topic><topic>Antigens, Fungal - blood</topic><topic>Aspergillosis</topic><topic>Aspergillosis - diagnosis</topic><topic>Aspergillosis - microbiology</topic><topic>Aspergillus</topic><topic>Aspergillus - isolation &amp; purification</topic><topic>Biological and medical sciences</topic><topic>Bone marrow</topic><topic>Bone Marrow Transplantation - adverse effects</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Disease Models, Animal</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fungal infections</topic><topic>Fungemia - diagnosis</topic><topic>Fungemia - microbiology</topic><topic>Fungi</topic><topic>Health care administration</topic><topic>Humans</topic><topic>Immunoenzyme Techniques</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Lung Diseases, Fungal - diagnosis</topic><topic>Lung Diseases, Fungal - microbiology</topic><topic>Male</topic><topic>Mannans - blood</topic><topic>Medical sciences</topic><topic>Microbiology</topic><topic>Middle Aged</topic><topic>Neutropenia</topic><topic>Rabbits</topic><topic>Sensitivity and Specificity</topic><topic>Symptoms</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marr, Kieren A.</creatorcontrib><creatorcontrib>Balajee, S. Arunmozhi</creatorcontrib><creatorcontrib>McLaughlin, Lisa</creatorcontrib><creatorcontrib>Tabouret, Marc</creatorcontrib><creatorcontrib>Bentsen, Christopher</creatorcontrib><creatorcontrib>Walsh, Thomas J.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marr, Kieren A.</au><au>Balajee, S. Arunmozhi</au><au>McLaughlin, Lisa</au><au>Tabouret, Marc</au><au>Bentsen, Christopher</au><au>Walsh, Thomas J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Detection of Galactomannan Antigenemia by Enzyme Immunoassay for the Diagnosis of Invasive Aspergillosis: Variables That Affect Performance</atitle><jtitle>The Journal of infectious diseases</jtitle><stitle>J Infect Dis</stitle><addtitle>J Infect Dis</addtitle><date>2004-08-01</date><risdate>2004</risdate><volume>190</volume><issue>3</issue><spage>641</spage><epage>649</epage><pages>641-649</pages><issn>0022-1899</issn><eissn>1537-6613</eissn><coden>JIDIAQ</coden><abstract>Invasive aspergillosis (IA) is a frequent complication of blood or marrow transplantation. Previous studies have reported that the Aspergillus galactomannan enzyme immunoassay (GM EIA) may be a useful diagnostic tool for IA, but its sensitivity is variable. We examined the performance of the GM EIA in 986 serum samples from 67 patients. Results demonstrated that decreasing the index cutoff for positivity to 0.5 increased its sensitivity, with minimal loss of specificity. The low cutoff increased the duration of test positivity before diagnosis by clinical means. Sensitivity was highest in patients who did not receive preventative mold-active antifungals (87.5%). A rabbit model demonstrated that the level of circulating antigen correlated with the tissue fungus burden. A quantifiable response to antifungal therapy in clinical samples and the rabbit model supports the development of this assay for early diagnosis and therapeutic monitoring. The 0.5 cutoff may allow for better performance as an early diagnostic test.</abstract><cop>Chicago, IL</cop><pub>The University Chicago Press</pub><pmid>15243943</pmid><doi>10.1086/422009</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1899
ispartof The Journal of infectious diseases, 2004-08, Vol.190 (3), p.641-649
issn 0022-1899
1537-6613
language eng
recordid cdi_proquest_miscellaneous_66688570
source MEDLINE; Jstor Complete Legacy; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection
subjects Adolescent
Adult
Aged
Animals
Antifungals
Antigens, Fungal - blood
Aspergillosis
Aspergillosis - diagnosis
Aspergillosis - microbiology
Aspergillus
Aspergillus - isolation & purification
Biological and medical sciences
Bone marrow
Bone Marrow Transplantation - adverse effects
Child
Child, Preschool
Disease Models, Animal
Female
Fundamental and applied biological sciences. Psychology
Fungal infections
Fungemia - diagnosis
Fungemia - microbiology
Fungi
Health care administration
Humans
Immunoenzyme Techniques
Infections
Infectious diseases
Lung Diseases, Fungal - diagnosis
Lung Diseases, Fungal - microbiology
Male
Mannans - blood
Medical sciences
Microbiology
Middle Aged
Neutropenia
Rabbits
Sensitivity and Specificity
Symptoms
title Detection of Galactomannan Antigenemia by Enzyme Immunoassay for the Diagnosis of Invasive Aspergillosis: Variables That Affect Performance
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T05%3A53%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Detection%20of%20Galactomannan%20Antigenemia%20by%20Enzyme%20Immunoassay%20for%20the%20Diagnosis%20of%20Invasive%20Aspergillosis:%20Variables%20That%20Affect%20Performance&rft.jtitle=The%20Journal%20of%20infectious%20diseases&rft.au=Marr,%20Kieren%20A.&rft.date=2004-08-01&rft.volume=190&rft.issue=3&rft.spage=641&rft.epage=649&rft.pages=641-649&rft.issn=0022-1899&rft.eissn=1537-6613&rft.coden=JIDIAQ&rft_id=info:doi/10.1086/422009&rft_dat=%3Cjstor_proqu%3E30077638%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=223912141&rft_id=info:pmid/15243943&rft_jstor_id=30077638&rft_oup_id=10.1086/422009&rfr_iscdi=true